PODXL also reportedly leads to increased in vitro migration and invasion, increased matrix metalloproteinase (MMP) expression, and increased activation of phosphatidylinositol 3-kinase (PI3K) in breast and prostate cancer cells (10). Here, PODXL is linked to prostate carcinoma.